$995.27 Million in Sales Expected for HealthSouth Corp (HLS) This Quarter

Brokerages forecast that HealthSouth Corp (NYSE:HLS) will report $995.27 million in sales for the current fiscal quarter, according to Zacks. Seven analysts have made estimates for HealthSouth’s earnings, with the highest sales estimate coming in at $1.01 billion and the lowest estimate coming in at $981.00 million. HealthSouth posted sales of $949.90 million in the same quarter last year, which would indicate a positive year over year growth rate of 4.8%. The business is expected to issue its next earnings results on Tuesday, February 20th.

On average, analysts expect that HealthSouth will report full year sales of $995.27 million for the current fiscal year, with estimates ranging from $3.89 billion to $3.95 billion. For the next year, analysts forecast that the business will report sales of $4.15 billion per share, with estimates ranging from $4.10 billion to $4.19 billion. Zacks Investment Research’s sales averages are a mean average based on a survey of research analysts that cover HealthSouth.

HealthSouth (NYSE:HLS) last announced its quarterly earnings data on Thursday, October 26th. The company reported $0.66 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $0.65 by $0.01. HealthSouth had a return on equity of 22.81% and a net margin of 6.69%. The firm had revenue of $995.60 million for the quarter, compared to analysts’ expectations of $985.75 million. During the same quarter in the prior year, the firm posted $0.65 earnings per share. HealthSouth’s revenue for the quarter was up 7.4% compared to the same quarter last year.

Several analysts have issued reports on HLS shares. Royal Bank of Canada restated a “buy” rating on shares of HealthSouth in a research note on Wednesday, November 15th. Mizuho raised HealthSouth from a “neutral” rating to a “buy” rating and set a $55.00 target price for the company in a report on Thursday, November 2nd. Robert W. Baird reaffirmed a “buy” rating and set a $55.00 target price on shares of HealthSouth in a report on Monday, October 9th. Zacks Investment Research raised HealthSouth from a “hold” rating to a “buy” rating and set a $52.00 target price for the company in a report on Monday, October 30th. Finally, Piper Jaffray Companies reaffirmed a “hold” rating and set a $50.00 target price on shares of HealthSouth in a report on Sunday, September 17th. Two research analysts have rated the stock with a sell rating, four have issued a hold rating and six have issued a buy rating to the stock. The company has a consensus rating of “Hold” and an average target price of $51.75.

In related news, Director Yvonne M. Curl bought 1,000 shares of the stock in a transaction dated Wednesday, November 1st. The stock was bought at an average cost of $45.95 per share, with a total value of $45,950.00. Following the completion of the acquisition, the director now owns 64,144 shares of the company’s stock, valued at $2,947,416.80. The purchase was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. 1.60% of the stock is currently owned by corporate insiders.

A number of hedge funds have recently modified their holdings of HLS. First Mercantile Trust Co. grew its holdings in HealthSouth by 18.8% in the 2nd quarter. First Mercantile Trust Co. now owns 2,720 shares of the company’s stock worth $132,000 after buying an additional 430 shares in the last quarter. Acrospire Investment Management LLC grew its holdings in HealthSouth by 64.7% in the 2nd quarter. Acrospire Investment Management LLC now owns 2,800 shares of the company’s stock worth $136,000 after buying an additional 1,100 shares in the last quarter. Advisor Group Inc. grew its holdings in HealthSouth by 33.8% in the 2nd quarter. Advisor Group Inc. now owns 3,092 shares of the company’s stock worth $149,000 after buying an additional 781 shares in the last quarter. Petrus Trust Company LTA bought a new position in HealthSouth in the 2nd quarter worth approximately $210,000. Finally, HL Financial Services LLC bought a new position in HealthSouth in the 2nd quarter worth approximately $213,000. 93.37% of the stock is owned by institutional investors and hedge funds.

Shares of HealthSouth (NYSE:HLS) traded up $0.40 during midday trading on Thursday, reaching $49.77. The company’s stock had a trading volume of 853,900 shares, compared to its average volume of 900,164. HealthSouth has a 12-month low of $38.24 and a 12-month high of $50.41. The firm has a market capitalization of $4,853.60, a PE ratio of 17.69, a P/E/G ratio of 1.82 and a beta of 0.54. The company has a debt-to-equity ratio of 1.89, a current ratio of 1.34 and a quick ratio of 1.34.

The business also recently announced a quarterly dividend, which will be paid on Tuesday, January 16th. Stockholders of record on Tuesday, January 2nd will be issued a dividend of $0.25 per share. This represents a $1.00 annualized dividend and a dividend yield of 2.01%. The ex-dividend date is Friday, December 29th. HealthSouth’s dividend payout ratio (DPR) is presently 36.36%.

COPYRIGHT VIOLATION NOTICE: “$995.27 Million in Sales Expected for HealthSouth Corp (HLS) This Quarter” was first reported by American Banking News and is owned by of American Banking News. If you are reading this piece of content on another publication, it was illegally stolen and republished in violation of United States & international trademark and copyright legislation. The correct version of this piece of content can be read at https://www.americanbankingnews.com/2017/12/14/995-27-million-in-sales-expected-for-healthsouth-corp-hls-this-quarter.html.

HealthSouth Company Profile

HealthSouth Corporation (HealthSouth) is a provider of post-acute healthcare services, offering both facility-based and home-based post-acute services in 35 states and Puerto Rico through its network of inpatient rehabilitation hospitals, home health agencies and hospice agencies. The Company manages its operations through segments, including inpatient rehabilitation, and home health and hospice.

Get a free copy of the Zacks research report on HealthSouth (HLS)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for HealthSouth (NYSE:HLS)

Receive News & Ratings for HealthSouth Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HealthSouth and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply